| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |